Population PK-PD Model for Tolerance Evaluation to the p38 MAP Kinase Inhibitor BCT197
用于评估 p38 MAP 激酶抑制剂 BCT197 耐受性的群体药代动力学-药效学模型
期刊:Cpt-Pharmacometrics & Systems Pharmacology
影响因子:3
doi:10.1002/psp4.12037
De Buck, S; Hueber, W; Vitaliti, A; Straube, F; Emotte, C; Bruin, G; Woessner, R
